A medical advance is the generation of information or a discovery of knowledge that improves our understanding in medical science, this is a significant breakthrough that results in an improvement of the diagnosis, treatment, and prevention of disease. As a trusted strategic advisor to healthcare and life science executives, we catalyze our clients’ success with insight, innovation, and integrity. Through our collaborative work and culture, we attract and develop outstanding professionals.
ImplantablRobot made to help dementia patients debuts at Minnesota nursing home
A Minnesota nursing home has begun using two AI-powered robots as care assistants for those with dementia or early-stage Alzheimer’s. The Pepper and NAO robots, both built by Softbank, were customized by roboticists at the University of Minnesota, Duluth to interact and enhance the independence of residents at The Estates of Roseville, followed by another seven nursing homes.
Implantable For Severe Paralysis
Approximately 1 in 50 Americans, or 5.4 million people, have some form of paralysis. While the cost of treatment is high, the value does not compare to the detrimental effects on patients. Most patients with paralysis experience a significant decline in their overall health. Recently, a team has offered new hope for these patients by leveraging implanted brain-computer interface technology to recover lost motor control and enable patients to control digital devices. The technology uses implanted electrodes to collect movement signals from the brain and decode them into movement commands. It has been shown to restore voluntary motor impulses in patients with severe paralysis due to brain, spinal cord, peripheral nerve or muscle dysfunction. While the interface technology is in its infancy, the FDA has designated the implantable a “breakthrough device,” reinforcing the need to move this novel technology to the bedside of patients who need it most.
Next Generation Of mRNA Vaccinology
Advancements in the generation, purification and cellular delivery of RNA have enabled the development of RNA therapies across a broad array of applications, such as cancer and Zika virus. The technology is cost-effective and relatively simple to manufacture. Furthermore, the COVID-19 pandemic demonstrated that the world needed rapid development of a vaccine that was easily deployable around the globe. Because of previous research that laid the groundwork for this technology, an effective COVID-19 vaccine was developed, produced, approved and deployed in less than a year. This landscape-changing technology has the potential to quickly and efficiently eliminate some of healthcare’s most challenging diseases.